CardioMet
SGLT2 inhibitors, lipid-lowering combinations and IV iron therapy for cardio-metabolic and renal care.
Advancing Pharmaceutical Healthcare in Myanmar — Global Pharmaceutical Expertise, Local Market Excellence
Our field teams already visit Myanmar's doctors, hospitals and pharmacies every day. What we build for the world's manufacturers is the bridge to them — a fully managed path from your factory to the prescribing physician.
Pair 23ANDME's on-the-ground commercial engine with ABCBIO Health FZCO's UAE trading base and you have one accountable partner for product development, registration, marketing and distribution across the country.
Why partner with 23ANDMEDeep command of Myanmar FDA registration and market-access requirements.
Experienced promotion across key therapeutic areas, doctor by doctor.
Cold-chain-ready logistics and nationwide reach to institutions and pharmacies.
Ethical promotion and strict regulatory compliance at every step.
ABCBIO Health FZCO is the group's UAE-registered trading and procurement entity, established under IFZA (the International Free Zone Authority) in Dubai. For manufacturers worldwide, ABCBIO is the contracting counterparty — the buyer that sources, consolidates and imports your products through one of the world's leading pharmaceutical trade hubs.
One accountable route from your production line to Myanmar's prescribing doctors — for in-licensing, product development, and long-term marketing.
Bring your innovative, quality-assured products seeking a trusted route into the Myanmar market.
Our UAE free-zone entity (IFZA, Dubai) contracts, sources and consolidates supply.
23ANDME secures Myanmar FDA registration and the market-access approvals your product needs.
Our field force promotes to doctors and pharmacies and distributes nationwide.
Three focused divisions give suppliers ready-built commercial channels into the conditions that matter most to Myanmar's clinicians — cardio-metabolic disease, heart failure and glycemic control, and gut health.
SGLT2 inhibitors, lipid-lowering combinations and IV iron therapy for cardio-metabolic and renal care.
Insulin mixes, ARNI heart-failure therapy and dual glycemic control with cardio-renal protection.
P-CAB acid suppression, adsorbent diarrhea therapy and probiotics for a balanced gut.
Sudhanshu Sharma brings deep expertise in market expansion, strategic operations and supply-chain management across Southeast Asia and Africa — including Regional Head for South East Asia, Country Head for Myanmar, and pan-African coverage of East & West Africa based out of Mumbai, at leading Indian multinationals.
Scientific symposia, product launches and exhibitions building real demand for our brands across Myanmar and the region.
If you're a global manufacturer seeking product development, registration and marketing in Myanmar, our team — and our UAE procurement arm ABCBIO Health FZCO — are ready to talk.
Start the conversation